Myeloma and its treatments can weaken the immune system and also result in a weaker response to COVID-19 vaccines. A Canadian study is looking at both vaccinated and unvaccinated people with myeloma to help doctors understand how they respond to COVID-19 vaccines, as well as how to best continue protecting them from infection. Funding for the study was awarded to the Ottawa Hospital by the Government of Canada’s COVID-19 Immunity Task Force (CITF).

More information:

• How well do COVID-19 vaccines work in people with cancer, immune deficiencies and other populations with health vulnerabilities?
• How well do COVID-19 vaccines work in people with blood cancer?